Selective amino acid deficiency in patients with impaired glucose tolerance and type 2 diabetes

Regulatory Peptides

Volumn 160, Issue 1-3, 2010, Pages 75-80

  Menge, Bjoern A ^a   Schrader, Henning ^a   Ritter, Peter R ^a   Ellrichmann, Mark ^a   Uhl, Waldemar ^a   Schmidt, Wolfgang E ^a   Meier, Juris J ^a  

^a ST JOSEF HOSPITAL   (Germany)

Author keywords

Amino acids; Arginine; Diabetes; Glutamine; IGT; Protein metabolism

Indexed keywords

4 AMINOBUTYRIC ACID; AMINO ACID; ARGININE; C PEPTIDE; ESSENTIAL AMINO ACID; GLUCAGON; GLUCOSE; GLUTAMINE; INSULIN; METFORMIN; PHOSPHOETHANOLAMINE; TYROSINE; VALINE;

ADULT; AMINO ACID BLOOD LEVEL; AMINO ACID DEFICIENCY; AMINO ACID METABOLISM; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; DIET RESTRICTION; DIET SUPPLEMENTATION; FEMALE; GLUCAGON BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN RESISTANCE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

AMINO ACIDS; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE INTOLERANCE; HUMANS; MALE; MIDDLE AGED; REFERENCE STANDARDS;

EID: 74749092317     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2009.08.001     Document Type: Article

References (29)

1. Crespin S.R., Greenough III W.B., and Steinberg D. Stimulation of insulin secretion by infusion of free fatty acids. J Clin Invest 48 10 (1969) 1934-1943
2. Raptis S., et al. Differences in insulin, growth hormone and pancreatic enzyme secretion after intravenous and intraduodenal administration of mixed amino acids in man. N Engl J Med 288 23 (1973) 1199-1202
3. van Loon L.J., et al. Amino acid ingestion strongly enhances insulin secretion in patients with long-term type 2 diabetes. Diabetes Care 26 3 (2003) 625-630
4. Wascher T.C., et al. Effects of low-dose L-arginine on insulin-mediated vasodilatation and insulin sensitivity. Eur J Clin Invest 27 8 (1997) 690-695
5. Henry R.R. Protein content of the diabetic diet. Diabetes Care 17 12 (1994) 1502-1513
6. Wijekoon E.P., et al. Amino acid metabolism in the Zucker diabetic fatty rat: effects of insulin resistance and of type 2 diabetes. Can J Physiol Pharmacol 82 7 (2004) 506-514
7. Nair K.S., et al. Protein dynamics in whole body and in splanchnic and leg tissues in type I diabetic patients. J Clin Invest 95 6 (1995) 2926-2937
8. Nair K.S., et al. Effect of poor diabetic control and obesity on whole body protein metabolism in man. Diabetologia 25 5 (1983) 400-403
9. Vollmer K., et al. Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance. Diabetes 57 3 (2008) 678-687
10. Meier J.J., et al. Reduced insulinotropic effect of gastric inhibitory polypeptide in first-degree relatives of patients with type 2 diabetes. Diabetes 50 11 (2001) 2497-2504
11. Deacon C.F., Johnsen A.H., and Holst J.J. Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo. J Clin Endocrinol Metab 80 3 (1995) 952-957
12. Deacon C.F., et al. Degradation of endogenous and exogenous gastric inhibitory polypeptide (GIP) in healthy and in Type 2 diabetic subjects as revealed using a new assay for the intact peptide. J Clin Endocrinol Metab 85 (2000) 3575-3581
13. Holst J.J. Evidence that enteroglucagon (II) is identical with the C-terminal sequence (residues 33-69) of glicentin. Biochem J 207 (1982) 381-388
14. Matthews D.R., et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 7 (1985) 412-419
15. Prentki M. New insights into pancreatic beta-cell metabolic signaling in insulin secretion. Eur J Endocrinol 134 3 (1996) 272-286
16. Larsson H., and Ahren B. Glucose-dependent arginine stimulation test for characterization of islet function: studies on reproducibility and priming effect of arginine. Diabetologia 41 7 (1998) 772-777
17. Cavagnini F., et al. Effects of gamma aminobutyric acid (GABA) and muscimol on endocrine pancreatic function in man. Metabolism 31 1 (1982) 73-77
18. Dong H., et al. Gamma-aminobutyric acid up- and downregulates insulin secretion from beta cells in concert with changes in glucose concentration. Diabetologia 49 4 (2006) 697-705
19. Wendt A., et al. Glucose inhibition of glucagon secretion from rat alpha-cells is mediated by GABA released from neighboring beta-cells. Diabetes 53 4 (2004) 1038-1045
20. Rorsman P., et al. Glucose-inhibition of glucagon secretion involves activation of GABAA-receptor chloride channels. Nature 341 6239 (1989) 233-236
21. von Blankenfeld G., et al. Expression of functional GABAA receptors in neuroendocrine gastropancreatic cells. Pflugers Arch 430 3 (1995) 381-388
22. Meier J.J., et al. Postprandial suppression of glucagon secretion depends on intact pulsatile insulin secretion: further evidence for the intraislet insulin hypothesis. Diabetes 55 4 (2006) 1051-1056
23. Volpi E., et al. Contribution of amino acids and insulin to protein anabolism during meal absorption. Diabetes 45 9 (1996) 1245-1252
24. Meier J.J., and Nauck M.A. Incretins and the development of type 2 diabetes. Curr Diab Rep 6 3 (2006) 194-201
25. Meier J.J., and Nauck M.A. Glucagon-like peptide 1(GLP-1) in biology and pathology. Diabetes Metab Res Rev 21 2 (2005) 91-117
26. Reimann F., et al. Glutamine potently stimulates glucagon-like peptide-1 secretion from GLUTag cells. Diabetologia 47 9 (2004) 1592-1601
27. Gameiro A., et al. The neurotransmitters glycine and GABA stimulate glucagon-like peptide-1 release from the GLUTag cell line. J Physiol 569 Pt 3 (2005) 761-772
28. Xu W., et al. Increased arginase II and decreased NO synthesis in endothelial cells of patients with pulmonary arterial hypertension. FASEB J 18 14 (2004) 1746-1748
29. Wu G. Amino acids: metabolism, functions, and nutrition. Amino Acids 37 1 (2009) 1-17